TARGET
saveCTLA-4
Cytotoxic T-lymphocyte-associated protein 4; immune checkpoint.
also known as: cd152, anti-ctla-4
drugs
0
catalysts
0
news
69
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- BioNTech says CTLA-4 drug nearly doubled survival times for lung cancerendpoints · 20d ago
- Summit, BioNTech, more headline WCLC with next-gen lung cancer drugsbiospace · 20d ago
- 5 drugmakers chasing Merck and Moderna in the cancer vaccine racebiospace · 21d ago
- BioNTech sets survival standard in hard-to-treat cancer ahead of pivotal readoutfiercebiotech · 23d ago
- Encoded raises $275M series F for Dravet syndrome gene therapybiospace · 24d ago
- Solstice rises with $225M to develop next-gen CTLA-4 drug from Chinabiospace · 25d ago
- A new immuno-oncology play raises $225M for a next-generation drugbiopharma dive · 25d ago
- Solstice rises with $225M series A to advance next-gen CTLA-4 immunotherapy into phase 2fiercebiotech · 26d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that